PROVIDER STATEMENT

Provided by HMP Education, an HMP Global Company.

INTENDED LEARNERS

This educational activity is specifically designed for physicians, physician associates, nurses, nurse practitioners, dietitians, and podiatrists.

LEARNING OBJECTIVES

After participating in this activity, learners should be better able to:

Wound Care Business Navigator: The ABCs of Wound Care Business - Understanding Coding & Compliance

• Identify core principles of wound care reimbursement, including appropriate documentation,coding, and reporting of services​
• Describe the end-to-end wound care revenue cycle, from clinical documentation and scheduling tocoding and claim submission​
• Recognize foundational requirements for accurate wound care claims submission and their impacton clinic financial performance

Wound Care Business Navigator: AI and Wound Care

• Evaluate and Implement AI-Driven Documentation Strategies: Identify the core differences between standard EHR templates and AI-augmented narratives and demonstrate how to utilize ambient listening and AI planimetry to improve clinical specificity, capture medical necessity, and reduce administrative “pajama time”
• Analyze and Mitigate 2026 Audit Risk Factors: Recognize the primary “red flags” used by payers and regulatory bodies (such as “cloned” documentation, measurement stagnation, and upcoding) and apply AI-supported gap analysis to align clinical records with Local Coverage Determinations (LCDs) and National Coverage Determinations (NCDs) prior to claim submission
• Navigate the Legal and Ethical Frameworks of AI in Medicine: Define the “Human-in-the-Loop” doctrine and its implications for physician liability, while assessing vendor adherence regarding HIPAA data sovereignty, “hallucination” management, and the legal requirements for patient disclosure of AI-assisted medical records

Wound Care Business Navigator: Creating Innovation in Wound Care

• Review current challenges and emerging opportunities in the wound care market. 
• Identify key market forces, reimbursement trends, and practice models that impact the financial performance of wound care programs and physician practices. 
• Analyze how adopting innovative wound care technologies and evidence-based treatment pathways can improve both clinical outcomes and profitability. 
• Develop strategies to survive the claw back audits. 

Wound Care Business Navigator: Mobile Health and Wound Care Panel Discussion

• Understand mobile wound care as a scalable business model
• Identify clinical governance structures that protect quality
• Recognize how technology enables value-based wound care
• Evaluate sustainable reimbursement strategies
• Anticipate future market shifts

Wound Care Business Navigator: Case Studies in Reimbursement

• Dissect complex reimbursement challenges encountered by wound/ulcer management professionals, as well as their billers and coders
• Analyze documentation, coding and billing pitfalls that may cause denials or repayments after an audit
• Develop strategies to receive appropriate payment and to keep payment after an audit

Wound Care Business Navigator: RAPID FIRE: Reimbursement in the Office Practice

• Learn what codes are important to know for wound care and how to use them  
• Learn what CCI Edits are and how they affect reimbursement
• Learn small procedures that can be done in a clinical setting and how to code them

Wound Care Business Navigator: RAPID FIRE: Reimbursement Insights for Financial Success of Hospital-Owned Outpatient Wound/Ulcer Management Provider-Based Departments

• Explore the business fundamentals of establishing and optimizing a successful hospital-owned outpatient wound/ulcer management PBD
• Acquire insight into key PBD operational components, including staff selection, product selection for conservative and advanced care, diagnostic devices, electronic health records, coding, and billing
• Explore the importance of involving administrators, physicians, clinicians, and pertinent revenue cycle colleagues in the operation of the PBD

Creating the Virtual Wound Team: Optimizing Patient Referrals

• Discuss typical scenarios leading to the development of a lawsuit​
• Identify critical practice areas under scrutiny inlawsuits​
• Develop an organizational and practice plan to stay out of the crossfire

RAPID FIRE: Staying out of Legal Crossfire

• Explain how to create a virtual wound team​
• Discuss how to develop an implementation plan​
• Measure the impact of the virtual team and how to address gaps

ACTIVITY OVERVIEW

This on-demand webcast is available with synchronized slides and video/audio.

To be eligible for documentation of credit for each session attended, learners must participate in each activity, complete each 4-question post-test with a minimum score of 70% and complete each activity evaluation. Participants who complete the evaluation online within 90 days of purchase will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone, or if your browser settings do not allow a new tab/window to open. 

Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy.

Release Date: May 13, 2026 
Expiration Date: 90 Days After Purchase
Last Available Date of Purchase: August 13, 2026
Estimated Time to Complete: 8 hours

There is no fee associated with this activity.

HARDWARE/SOFTWARE REQUIREMENTS

The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. 

CONTINUING EDUCATION

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.

PHYSICIANS

HMP Education designates this internet enduring activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

This continuing nursing education internet enduring activity awards 8 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #18006, for 8 contact hours. 

NURSE PRACTITIONERS

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit^TM from organizations accredited by the ACCME.

PHYSICIAN ASSOCIATES

HMP Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 8 AAPA Category 1 credits. Approval is valid until November 13, 2026. PAs should only claim credit commensurate with the extent of their participation.

DIETITIANS

PODIATRISTS

HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this internet enduring activity for a maximum of 8 continuing education contact hours.

INTERNATIONAL RECOGNITION

Visit this link for countries and regions have reciprocity with the ACCME.  

Visit this link for additional countries that accept ACCME-accredited continuing medical education (CME). 

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters, or moderators and do not necessarily reflect the opinions of HMP Education.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own healthcare provider.

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority. 

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to and mitigating all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME. 

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose: 

1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;  

2. Any investigational, off-label, or non-FDA approved content or discussion 

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner. 

Education has been independently peer-reviewed to validate content, including any AI-supported elements, mitigate identified financial relationships (conflicts of interest), and ensure: 

1. All recommendations involving clinical medicine are based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients. 

2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis. 

3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional. 

All relevant financial relationships have been mitigated.

FACULTY

The faculty have reported the following: 

Karen Cross, MD, PhD, FRCSC: Employee/Owner-Mimosa Diagnostics

Ryan Dirks, MS, PA-C​: Speaker’s Bureau-Reprise BioMedical

Amanda Estapa, APRN, CWS: Nothing to disclose in relation to this activity​

Maria Goddard, MD, CWS, MAPWCA: Advisory Board-Medline, Tissue Health Plus; Consultant-Hartmann, Medline, Solventum, vTail; Employee/Owner-CVS; Speaker's Bureau-Medline; Royalties/Patent Income-Medmastery

Jonathan Johnson, MD, MBA, CWSP, FAPWCA: Nothing to disclose in relation to this activity​

Traci A. Kimball, MD, MBA, CWSP: Advisory Board/Consultant/Speaker's Bureau/Grant/Research Support-3M, Aroa, Asclepii, Convatec, Halyard, Hartmann, Histologics, Kane BioTech, LaVior, Merakris Therapeutics, Mimosa Diagnostics, NuEyes

Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC, CPMA, CEMC: Employee/Owner-Lehrman Consulting, LLC

Eric Lullove, DPM: Scientific Advisor/Research Grant-MedAxis, Reprise Biomedical, Legacy Medical; Consultant-Legacy Medical, WoundZoom, Dermasensor, Athelas/Commure, ETS; Speaker Bureau-ETS, NextGen, Kerecis; Planning Committee-Member for SAWC 2026; Editorial Advisory Board Member-Wounds, JWC and HMP Business of Wound Care 

Patrick McEneaney, DPM, FACFAS, AAPWCA: Advisory Board-RMR Orthopedics; Consultant: Kerecis, Biocomposites, RMR Orthopedics, Irrisept; Research-Kerecis; Investor-RMR Orthopedics

Shawn Navqi, MD: Nothing to disclose in relation to this activity​

Lee C. Ruotsi, MD, ABWMS, CWS-P, UHM: Advisoy Board/Speaker's Bureau-Molnlycke Health Care; Consultant/Speaker's Bureau-Smith&Nephew 

Kathleen D. Schaum, MS: Nothing to disclose in relation to this activity​

Thomas E. Serena MD FACS FACHM, FAPWCA: Receives research support from: Axolotl Biologix, Biolab Holdings, Applied Biologics, Bluedrop Medical, C5 Biomedical, Terraplasma, Convatec, Cytora, DebX, Gelformed, Integra, Kerecis, LxBio, MiMedix, Natrox, MolecuLight, Samaritan, Sequence Life, Stability Biologics, Tiger Biosciences, Organogenesis, and StimLabs.

CLINICAL REVIEWERS

Robert S. Kirsner, MD, PhD, FAAD
Chairman and Harvey Blank Chair
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
Director, University of Miami Hospital and Clinics Wound Center
University of Miami Miller School of Medicine
Miami, Florida

Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California

Lee C. Ruotsi, MD, ABWMS, CWS-P, UHM
Medical Director
Holland Hospital
Holland, Michigan
 

Robert Kirsner, MD, PhD, FAAD: Consultant – Cell Constructs Inc.

Lee C. Ruotsi, MD, ABWMS, CWS-P, UHM: Advisoy Board/Speaker's Bureau-Molnlycke Health Care; Consultant/Speaker's Bureau-Smith&Nephew 

Susie Seaman, NP, MSN, CWCN, CWS: has disclosed no relevant financial relationship with any ineligible company (commercial interest). 
 

PLANNING COMMITTEE

Planning for this activity was conducted by faculty advisors. To further support the development of the content, additional information regarding professional roles, responsibilities, and teamwork was gathered through survey input from our target audience and/or a comprehensive literature review.  

HMP Education planners and staff include Sam Bella; Daivid DePinho; MaryEllen Fama; Mary Johnson; Samantha Joy; Randy Robbin; and Andrea Zimmerman, EdD, CHCP. No HMP Education staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA STATEMENT

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. Any participant in this educational activity who needs accommodation(s) may submit a request to the support team. 

PRIVACY POLICY

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. 

COMMERCIAL SUPPORT

No commercial interest provided financial support for this continuing education activity. 

CONTACT US 

For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant, which can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please contact the support team. Our accreditation and compliance team will respond to your inquiry within one business day.      

Copyright © 2026 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.